Litigation Details for UCB, Inc. v. Cipla Limited (D. Del. 2021)
UCB, Inc. v. Cipla Limited (D. Del. 2021)
| Docket | 1:21-cv-01229 | Date Filed | 2021-08-26 |
| Court | District Court, D. Delaware | Date Terminated | 2026-05-27 |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
| Jury Demand | None | Referred To | |
| Parties | CIPLA LIMITED | ||
| Patents | 10,183,004; 10,183,005; 10,183,012; 10,337,003; 11,001,578; 11,524,008; 12,146,003; 12,194,005; 8,217,033; 8,399,015; 8,809,322; 9,289,432; 9,415,016; 9,623,014; 9,657,021; 9,669,009; 9,687,495 | ||
| Attorneys | Alexa R. Hansen | ||
| Firms | Morris James LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB, Inc. v. Cipla Limited
Details for UCB, Inc. v. Cipla Limited (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-08-26 | External link to document | |||
| 2021-08-26 | 111 | Notice of Service | Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495; and…Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495 filed… 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-08-26 | 117 | Notice of Service | Hugh Smyth Regarding the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322 filed by Hananja EHF, UCB … 26 August 2021 1:21-cv-01229 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
